
Keywords: ADCC; antibody-dependent cellular cytotoxicity; CDC; complement-dependent cytotoxicity; cDNA; complementary DNA; CEL-seq; single-cell RNA-sequencing; DOC; doxorubicin; EMA; European Medicines Agency; ER; estrogen receptor; FRα; folate receptor alpha; HER